TAUNS Laboratories,Inc. Cash Flow Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Net Income	5,774	3,035
Depreciation & Amortization	676.16	639.97
Loss (Gain) From Sale of Assets	6.16	0.74
Loss (Gain) From Sale of Investments	1.67	297.85
Other Operating Activities	2,360	-4,104
Change in Accounts Receivable	344.38	-2,109
Change in Inventory	-130.53	1.44
Change in Accounts Payable	339.34	-247.46
Change in Other Net Operating Assets	563.45	-672.37
Operating Cash Flow	9,935	-3,158
Capital Expenditures	-3,753	-1,090
Sale of Property, Plant & Equipment	2.1	1.22
Sale (Purchase) of Intangibles	-208.02	-75.84
Investment in Securities	-151.28	-450.85
Other Investing Activities	-	-0
Investing Cash Flow	-4,110	-1,615
Short-Term Debt Issued	1,000	2,300
Long-Term Debt Issued	2,699	-
Total Debt Issued	3,699	2,300
Long-Term Debt Repaid	-732	-732
Net Debt Issued (Repaid)	2,967	1,568
Issuance of Common Stock	5.68	1.8
Common Dividends Paid	-600	-1,900
Other Financing Activities	-16.48	-
Financing Cash Flow	2,356	-330.2
Miscellaneous Cash Flow Adjustments	-	-0
Net Cash Flow	8,181	-5,103
Free Cash Flow	6,182	-4,247
Free Cash Flow Margin	33.53%	-27.10%
Free Cash Flow Per Share	57.80	-42.47
Cash Interest Paid	29.02	21.81
Cash Income Tax Paid	455.05	5,483
Levered Free Cash Flow	5,392	-
Unlevered Free Cash Flow	5,412	-
Change in Net Working Capital	-3,678	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.